Increased microRNA-155 expression in the serum and peripheral monocytes in chronic HCV infection

Journal of Translational Medicine

Volumn 10, Issue 1, 2012, Pages

  Bala, Shashi ^a   Tilahun, Yaphet ^a   Taha, Odette ^a   Alao, Hawau ^a   Kodys, Karen ^a   Catalano, Donna ^a   Szabo, Gyongyi ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

ALT; Biomarker; Inflammation; MiR 122; MiR 125b; MiR 155

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; LIPOPOLYSACCHARIDE; MICRORNA 122; MICRORNA 125B; MICRORNA 146A; MICRORNA 155; NONSTRUCTURAL PROTEIN 3; NONSTRUCTURAL PROTEIN 5; RECOMBINANT PROTEIN; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 8; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IN VIVO STUDY; LIVER CELL DAMAGE; MALE; MONOCYTE; PROTEIN EXPRESSION; PROTEIN INDUCTION; UPREGULATION;

ADULT; BASE SEQUENCE; CASE-CONTROL STUDIES; DNA PRIMERS; FEMALE; HEPATITIS C, CHRONIC; HUMANS; MALE; MICRORNAS; MIDDLE AGED; MONOCYTES; REAL-TIME POLYMERASE CHAIN REACTION; TOLL-LIKE RECEPTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84864337139     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-10-151     Document Type: Article

References (44)

1. Rehermann B, Hepatitis C. virus versus innate and adaptive immune responses: A tale of coevolution and coexistence. J Clin Invest 2009, 119(7):1745-1754. 10.1172/JCI39133, 2701885, 19587449.
2. Matsuzaki K, Murata M, Yoshida K, Sekimoto G, Uemura Y, Sakaida N, Kaibori M, et al. Chronic inflammation associated with hepatitis C virus infection perturbs hepatic transforming growth factor beta signaling, promoting cirrhosis and hepatocellular carcinoma. Hepatology 2007, 46(1):48-57. 10.1002/hep.21672, 17596875.
3. Emmanouil K, Pelagia F, Penelope M. Modulation of monocyte/macrophage-derived cytokine and chemokine expression profile by persistent hepatitis C virus (HCV) infection leads to chronic inflammation. Journal of Molecular Biochemistry 2012, 1:40-53.
4. Heydtmann M. Macrophages in hepatitis B and hepatitis C virus infections. J Virol 2009, 83(7):2796-2802. 10.1128/JVI.00996-08, 2655563, 18842723.
5. Mencin A, Kluwe J, Schwabe RF. Toll-like receptors as targets in chronic liver diseases. Gut 2009, 58(5):704-720. 10.1136/gut.2008.156307, 2791673, 19359436.
6. Dolganiuc A, Norkina O, Kodys K, Catalano D, Bakis G, Marshall C, Mandrekar P, et al. Viral and host factors induce macrophage activation and loss of toll-like receptor tolerance in chronic HCV infection. Gastroenterology 2007, 133(5):1627-1636. 10.1053/j.gastro.2007.08.003, 2593079, 17916356.
7. Napoli J, Bishop GA, McGuinness PH, Painter DM, McCaughan GW. Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines. Hepatology 1996, 24(4):759-765. 10.1002/hep.510240402, 8855173.
8. Pal S, Shuhart MC, Thomassen L, Emerson SS, Su T, Feuerborn N, Kae J, et al. Intrahepatic hepatitis C virus replication correlates with chronic hepatitis C disease severity in vivo. J Virol 2006, 80(5):2280-2290. 10.1128/JVI.80.5.2280-2290.2006, 1395397, 16474135.
9. Dolganiuc A, Oak S, Kodys K, Golenbock DT, Finberg RW, Kurt-Jones E, Szabo G. Hepatitis C core and nonstructural 3 proteins trigger toll-like receptor 2-mediated pathways and inflammatory activation. Gastroenterology 2004, 127(5):1513-1524. 10.1053/j.gastro.2004.08.067, 15521019.
10. Chang S, Dolganiuc A, Szabo G. Toll-like receptors 1 and 6 are involved in TLR2-mediated macrophage activation by hepatitis C virus core and NS3 proteins. J Leukoc Biol 2007, 82(3):479-487. 10.1189/jlb.0207128, 17595379.
11. Hosomura N, Kono H, Tsuchiya M, Ishii K, Ogiku M, Matsuda M, Fujii H. HCV-related proteins activate kupffer cells isolated from human liver tissues. Dig Dis Sci 2011, 56(4):1057-1064. 10.1007/s10620-010-1395-y, 20848204.
12. Machida K, Cheng KT, Pavio N, Sung VM, Lai MM. Hepatitis C virus E2-CD81 interaction induces hypermutation of the immunoglobulin gene in B cells. J Virol 2005, 79(13):8079-8089. 10.1128/JVI.79.13.8079-8089.2005, 1143751, 15956553.
13. Szabo G, Dolganiuc A. Hepatitis C and innate immunity: Recent advances. Clin Liver Dis 2008, 12(3):675-692. 10.1016/j.cld.2008.03.003, 2593077, 18625434.
14. O'Neill LA, Sheedy FJ, McCoy CE. MicroRNAs: The fine-tuners of toll-like receptor signalling. Nat Rev Immunol 2011, 11(3):163-175. 10.1038/nri2957, 21331081.
15. Nahid MA, Satoh M, Chan EK. Mechanistic role of MicroRNA-146a in endotoxin-induced differential cross-regulation of TLR signaling. J Immunol 2011, 186(3):1723-1734. 10.4049/jimmunol.1002311, 21178010.
16. Pang M, Bala S, Kodys K, Catalano D, Szabo G. Inhibition of TLR8- and TLR4-induced type I IFN induction by alcohol is different from its effects on inflammatory cytokine production in monocytes. BMC Immunol 2011, 12:55. 10.1186/1471-2172-12-55, 3203086, 21962237.
17. Bala S, Marcos M, Kodys K, Csak T, Catalano D, Mandrekar P, Szabo G. Up-regulation of microRNA-155 in macrophages contributes to increased tumor necrosis factor alpha (TNF{alpha}) production via increased mRNA half-life in alcoholic liver disease. J Biol Chem 2011, 286(2):1436-1444. 10.1074/jbc.M110.145870, 3020752, 21062749.
18. Waggoner SN, Hall CH, Hahn YS. HCV core protein interaction with gC1q receptor inhibits Th1 differentiation of CD4+ T cells via suppression of dendritic cell IL-12 production. J Leukoc Biol 2007, 82(6):1407-1419. 10.1189/jlb.0507268, 17881511.
19. Tili E, Michaille JJ, Cimino A, Costinean S, Dumitru CD, Adair B, Fabbri M, et al. Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. J Immunol 2007, 179(8):5082-5089.
20. Larrea E, Garcia N, Qian C, Civeira MP, Prieto J. Tumor necrosis factor alpha gene expression and the response to interferon in chronic hepatitis C. Hepatology 1996, 23(2):210-217.
21. Dolganiuc A, Chang S, Kodys K, Mandrekar P, Bakis G, Cormier M, Szabo G. Hepatitis C virus (HCV) core protein-induced, monocyte-mediated mechanisms of reduced IFN-alpha and plasmacytoid dendritic cell loss in chronic HCV infection. J Immunol 2006, 177(10):6758-6768.
22. Etheridge A, Lee I, Hood L, Galas D, Wang K. Extracellular microRNA: A new source of biomarkers. Mutat Res 2011, 717(1-2):85-90. 10.1016/j.mrfmmm.2011.03.004, 3199035, 21402084.
23. Ji F, Yang B, Peng X, Ding H, You H, Tien P. Circulating microRNAs in hepatitis B virus-infected patients. J Viral Hepat 2011, 18(7):e242-e251. 10.1111/j.1365-2893.2011.01443.x, 21692939.
24. Xu J, Wu C, Che X, Wang L, Yu D, Zhang T, Huang L, et al. Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis. Mol Carcinog 2011, 50(2):136-142. 10.1002/mc.20712, 21229610.
25. Zhang Y, Jia Y, Zheng R, Guo Y, Wang Y, Guo H, Fei M, et al. Plasma MicroRNA-122 as a biomarker for viral-, alcohol-, and chemical-related hepatic diseases. Clin Chem 2010, 56(12):1830-1838. 10.1373/clinchem.2010.147850, 20930130.
26. Starkey Lewis PJ, Dear J, Platt V, Simpson KJ, Craig DG, Antoine DJ, French NS, et al. Circulating microRNAs as potential markers of human drug-induced liver injury. Hepatology 2011, 54(5):1767-1776. 10.1002/hep.24538, 22045675.
27. Riordan SM, Skinner NA, Kurtovic J, Locarnini S, McIver CJ, Williams R, Visvanathan K. Toll-like receptor expression in chronic hepatitis C: Correlation with pro-inflammatory cytokine levels and liver injury. Inflamm Res 2006, 55(7):279-285. 10.1007/s00011-006-0082-0, 16955390.
28. Falasca K, Ucciferri C, Dalessandro M, Zingariello P, Mancino P, Petrarca C, Pizzigallo E, et al. Cytokine patterns correlate with liver damage in patients with chronic hepatitis B and C. Ann Clin Lab Sci 2006, 36(2):144-150.
29. O'Connell RM, Rao DS, Baltimore D. MicroRNA regulation of inflammatory responses. Annu Rev Immunol 2012, 30:295-312. 10.1146/annurev-immunol-020711-075013, 22224773.
30. Thai TH, Calado DP, Casola S, Ansel KM, Xiao C, Xue Y, Murphy A, et al. Regulation of the germinal center response by microRNA-155. Science (New York, N Y 2007, 316(5824):604-608.
31. O'Connell RM, Taganov KD, Boldin MP, Cheng G, Baltimore D. MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci U S A 2007, 104(5):1604-1609. 10.1073/pnas.0610731104, 1780072, 17242365.
32. Kutty RK, Nagineni CN, Samuel W, Vijayasarathy C, Hooks JJ, Redmond TM. Inflammatory cytokines regulate microRNA-155 expression in human retinal pigment epithelial cells by activating JAK/STAT pathway. Biochem Biophys Res Commun 2010, 402(2):390-395. 10.1016/j.bbrc.2010.10.042, 2992362, 20950585.
33. Sidorkiewicz M, Grek M, Jozwiak B, Majda-Stanislawska E, Piekarska A, Bartkowiak J. Expression of microRNA-155 precursor in peripheral blood mononuclear cells from hepatitis C patients after antiviral treatment. Acta Virol 2010, 54(1):75-78. 10.4149/av_2010_01_75, 20201617.
34. Grek M, Piekarska A, Bartkowiak J, Fendler W, Kuydowicz J, Wroblewski P, Paradowski M, et al. Coordinated increase of miRNA-155 and miRNA-196b expression correlates with the detection of the antigenomic strand of hepatitis C virus in peripheral blood mononuclear cells. Int J Mol Med 2011, 28(5):875-880.
35. Descamps V, Op de Beeck A, Plassart C, Brochot E, Francois C, Helle F, Adler M, et al. Strong correlation between liver and serum levels of hepatitis C virus core antigen and RNA in chronically infected patients. J Clin Microbiol 2012, 50(2):465--468. 10.1128/JCM.06503-11, 3264181, 22162563.
36. Imran M, Waheed Y, Manzoor S, Bilal M, Ashraf W, Ali M, Ashraf M. Interaction of hepatitis C virus proteins with pattern recognition receptors. Virol J 2012, 9(1):126.
37. Wang H, Tan G, Dong L, Cheng L, Li K, Wang Z, Luo H. Circulating MiR-125b as a marker predicting chemoresistance in breast cancer. PLoS One 2012, 7(4):e34210. 10.1371/journal.pone.0034210, 3327688, 22523546.
38. Kong L, Zhu J, Han W, Jiang X, Xu M, Zhao Y, Dong Q, et al. Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: A clinical study. Acta Diabetol 2011, 48(1):61-69. 10.1007/s00592-010-0226-0, 20857148.
39. Negro F, Alaei M. Hepatitis C virus and type 2 diabetes. World J Gastroenterol 2009, 15(13):1537-1547. 10.3748/wjg.15.1537, 2669937, 19340895.
40. Bala S, Szabo G. MicroRNA signature in alcoholic liver disease. Int J Hepatol 2012, 2012:498232. 3296165, 22518321.
41. Singal AK, Kuo YF, Anand BS. Hepatitis C virus infection in alcoholic hepatitis: Prevalence patterns and impact on in-hospital mortality. Eur J Gastroenterol Hepatol 2012,
42. Fichtlscherer S, De Rosa S, Fox H, Schwietz T, Fischer A, Liebetrau C, Weber M, et al. Circulating microRNAs in patients with coronary artery disease. Circ Res 2010, 107(5):677-684. 10.1161/CIRCRESAHA.109.215566, 20595655.
43. Bihrer V, Friedrich-Rust M, Kronenberger B, Forestier N, Haupenthal J, Shi Y, Peveling-Oberhag J, et al. Serum miR-122 as a biomarker of necroinflammation in patients with chronic hepatitis C virus infection. Am J Gastroenterol 2011, 106(9):1663-1669. 10.1038/ajg.2011.161, 21606975.
44. Cermelli S, Ruggieri A, Marrero JA, Ioannou GN, Beretta L. Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease. PLoS One 2011, 6(8):e23937. 10.1371/journal.pone.0023937, 3160337, 21886843.